Tau modifiers as therapeutic targets for Alzheimer's disease.

Liu Q, Lee HG, Honda K, Siedlak SL, Harris PL, Cash AD, Zhu X, Avila J, Nunomura A, Takeda A, Smith MA, Perry G. Tau modifiers as therapeutic targets for Alzheimer's disease. Biochim Biophys Acta. 2005 Jan 03; 1739(2-3):211-5.

View in: PubMed

subject areas

Aldehydes
Alzheimer Disease
Animals
Guanosine
Humans
Mice
Nerve Degeneration
Neurofibrillary Tangles
Oxidative Stress
Phosphorylation
tau Proteins

authors with profiles

George Perry

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support